Published Studies
Synopsis T cells that infiltrate tumors often become exhausted and lose their ability to fight cancer due to poor mitochondrial function and reduced mitophagy. This exhaustion involves lasting cha...
Read moreThe Effects of Nutraceutical and Drug Cocktails in Duchenne Muscular Dystrophy: Preclinical Findings
Synopsis Duchenne muscular dystrophy (DMD) causes muscle weakness leading to respiratory failure. Earlier, quercetin showed temporary respiratory benefits in a mouse model. This study tested querc...
Read moreNicotinamide Riboside Decreased DNA Damage in Liver Cells: Preclinical Findings
Synopsis Hepatocellular carcinoma (HCC) is a fast-growing liver cancer, but its exact origin has been unclear. Using human data and mouse models, researchers found that HCC starts mainly from live...
Read moreNicotinamide Riboside Reduces Liver Inflammation and DNA Damage: Preclinical Findings
Synopsis Obesity increases the risk of liver cancer (hepatocellular carcinoma, HCC), but the exact mechanisms were unclear. This study found that a liver protein called URI links excess nutrients ...
Read moreInhibition of NAMPT and CD73 Suppresses Tumor Growth: Preclinical Findings
Synopsis Researchers are exploring new ways to treat ovarian cancer by targeting how tumor cells produce and recycle energy. This study focused on NAD+, a key molecule for cellular metabolism, and...
Read moreIncreasing NAD+ with Nicotinamide Riboside Prevents Liver Cancer Driven by URI: Preclinical Findings
Synopsis The molecular causes of liver cancer (hepatocellular carcinoma, HCC) are not fully understood. This study used genetically modified mice to show that when liver cells produce too much of ...
Read moreNR and NMN Influence NAD+ Metabolism to Improve Anti-Cancer Therapy: Preclinical Findings
Synopsis In human cells, NAD+ is mainly produced through “salvage” pathways that recycle precursors like nicotinamide, nicotinic acid, and nicotinamide riboside (NR). Blocking this process with th...
Read more